Purpose
The purpose of student discussions is to provide the opportunity for deeper understanding of polypharmacy
Activity Learning Outcomes
Through this discussion, the student will demonstrate the ability to:
- Summarize the different polypharmacy definitions found within the literature. (WO1.5) (CO1)
- Discuss polypharmacy risk factors (WO1.5) (CO1)
- Explain thee actions steps for polypharmacy prevention (WO1.5) (CO1, 7)
Due Date:
The initial posting to the graded collaborative discussions is due by Wednesday, 11:59 p.m. MT.
Peer responses and responses to faculty must be posted prior to the week deadline of Sunday 11:59 MT.
A 10% late penalty will be imposed for discussions posted after the deadline on Wednesday, regardless of the number of days late. NOTHING will be accepted after 11:59pm MT on Sunday (i.e. student will receive an automatic 0).
Total Points Possible:
50 points
Requirements:
Your initial discussion post should include the following:
- Identify and discuss 2-3 definitions of polypharmacy (there are multiple definitions). Your textbook can count as 1 reference. You must also include an additional reference from an evidence-based practice journal article or national guideline.
- Identify three risk factors that can lead to polypharmacy. Explain the rationale for why each listed item is a risk factor. Risk factors are different than adverse drug reactions.ADRs can be a result of polypharmacy, and is important, but ADRs are not a risk factor.
- Explore three action steps that a provider can take to prevent polypharmacy.
- Provide an example of how your clinical preceptors have addressed polypharmacy.
Solution:
The existing literature considers the concept of polypharmacy as a dynamic term used to refer to the wrong administration of prescribing drugs. According to Morin, Johnell, Laroche, Fastbom, and Wastesson (2018), polypharmacy is the excess administration of medications for a specific health condition especially among the aged suffering from chronic illnesses. Another meaning of polypharmacy is prescribing more drugs than it is clinically acceptable (Johansson et al., 2016).In this case, the absence of a reason to give out more drugs than necessary makes it inappropriate and unjust. Dang, Nguyen and Ho (2019) describe polypharmacy as the simultaneous application of similar drugs to treat the same type of disease.
Polypharmacy is typically associated not only with the use of multiple medications but also with the use of numerous pharmacies. Usually, a single pharmacy/ pharmacist can notice an unusual number of medicines that a patient may be taking, and either reach out to the person or his/her physician. However, several risk factors increase polypharmacy. The frailty of a patient’s decreased mental and physical health state, weakness, obesity, and multimorbidity are the vital risks of polypharmacy (Morin et al., 2018). First, diabetes disorder is a significant risk factor for……….Please click the icon below to purchase full answer at only $10